Big Data: transforming drug development and health policy decision making
Knowledge Source Identification | |
---|---|
Knowledge source name | Big Data: transforming drug development and health policy decision making |
Owner/Developer | Health Services & Outcomes Research Methodology |
Country | United States of America |
Languages | English |
URL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987387/ |
Description | The explosion of data sources, accompanied by the evolution of technology and analytical techniques, has created considerable challenges and opportunities for drug development and healthcare resource utilization. We present a systematic overview these phenomena, and suggest measures to be taken for effective integration of the new developments in the traditional medical research paradigm and health policy decision making. Special attention is paid to pertinent issues in emerging areas, including rare disease drug development, personalized medicine, Comparative Effectiveness Research, and privacy and confidentiality concerns. |
Knowledge Source Category | |
Category | Publication |
Sub categories | Review / Research article |
Knowledge Dissemination and Sharing | |
Dissemination channel | Website |
Targeted audience (specified/objective analysis) | Researchers, Scientists, Industry |
Users access | Open access |
Knowledge Characterization | |
3Rs relevance | Replacement, Reduction |
Purpose | Documentation and information |